glp 1 side effects long term Long-term Success of GLP-1s Hinges on More Than Just a Prescription Comparing GLP‑1 Drugs With Other

The random effects model was used regardless of heterogeneity scores, based on evidence of more robust estimates when compared to fixed-effect models [31,32,33]

According to FDA prescribing information, these include: Nausea (occurring in 1544% of patients depending on the specific agent and dose) Vomiting (524% of patients) Diarrhea (821% of patients) Constipation (1024% of patients) Abdominal pain or discomfort (514% of patients) These symptoms typically emerge during dose initiation or escalation and often diminish over several weeks as the body adapts

Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion

Maffulli, N